Deep search
All
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Search
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Most recent
Best match
25m
on MSN
Novo Nordisk Earnings Must Show GLP-1 Market Still Set for Big Growth
Novo’s Wegovy and Ozempic are among the most closely watched new medications in recent history, but face serious competition from Eli Lilly’s Zepbound and Mounjaro.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Wins Senate committee vote
RFK Jr. clears Senate panel
Imposes tariffs on US goods
Sweden school shooting
Pauses tariffs on Canada, MX
Antitrust violation probe
Sued by former nanny
US, Philippines joint patrol
Accused attacker faces trial
Offers to jail US criminals
Biden signs with CAA
To block Trump nominees
Announces death of mother
To cut up to 7,000 jobs
To launch streaming service
EPA warns employees
Sued for discrimination
Suspended 10 games
DOJ to battle antisemitism
‘Squid Game' actress dies
Fund freeze block extended
FSU coach stepping down
US job openings fall
Inks deal with SK’s Kakao
Stradivarius violin auction
Recall upgraded to Class I
Neo-Nazi leader convicted
MLB fires Pat Hoberg
Microplastics found in brains
Former Astros coach dies
Feedback